214 related articles for article (PubMed ID: 16263653)
1. No correlation between radiosensitivity or double-strand break repair capacity of normal fibroblasts and acute normal tissue reaction after radiotherapy of breast cancer patients.
El-Awady RA; Mahmoud M; Saleh EM; El-Baky HA; Lotayef M; Dahm-Daphi J; Dikomey E
Int J Radiat Biol; 2005 Jul; 81(7):501-8. PubMed ID: 16263653
[TBL] [Abstract][Full Text] [Related]
2. Huge differences in cellular radiosensitivity due to only very small variations in double-strand break repair capacity.
Kasten-Pisula U; Tastan H; Dikomey E
Int J Radiat Biol; 2005 Jun; 81(6):409-19. PubMed ID: 16249159
[TBL] [Abstract][Full Text] [Related]
3. Correlation between DNA repair capacity in lymphocytes and acute side effects to skin during radiotherapy in nasopharyngeal cancer patients.
Wang WD; Chen ZT; Li DZ; Cao ZH; Sun SL; Pu P; Chen XP
Clin Cancer Res; 2005 Jul; 11(14):5140-5. PubMed ID: 16033828
[TBL] [Abstract][Full Text] [Related]
4. Individual radiosensitivity measured with lymphocytes may predict the risk of acute reaction after radiotherapy.
Borgmann K; Hoeller U; Nowack S; Bernhard M; Röper B; Brackrock S; Petersen C; Szymczak S; Ziegler A; Feyer P; Alberti W; Dikomey E
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):256-64. PubMed ID: 18406889
[TBL] [Abstract][Full Text] [Related]
5. DNA double-strand break induction and repair in irradiated lymphoblastoid, fibroblast cell lines and white blood cells from ATM, NBS and radiosensitive patients.
Strasser H; Grabenbauer GG; Sprung CN; Sauer R; Distel LV
Strahlenther Onkol; 2007 Aug; 183(8):447-53. PubMed ID: 17680225
[TBL] [Abstract][Full Text] [Related]
6. In vitro radiosensitivity measured in lymphocytes and fibroblasts by colony formation and comet assay: comparison with clinical acute reactions to radiotherapy in breast cancer patients.
Oppitz U; Schulte S; Stopper H; Baier K; Müller M; Wulf J; Schakowski R; Flentje M
Int J Radiat Biol; 2002 Jul; 78(7):611-6. PubMed ID: 12079540
[TBL] [Abstract][Full Text] [Related]
7. Comparison between pulsed-field gel electrophoresis and the comet assay as predictive assays for radiosensitivity in fibroblasts.
Sarkaria JN; Bush C; Eady JJ; Peacock JH; Steel GG; Yarnold JR
Radiat Res; 1998 Jul; 150(1):17-22. PubMed ID: 9650597
[TBL] [Abstract][Full Text] [Related]
8. Early and late skin reactions to radiotherapy for breast cancer and their correlation with radiation-induced DNA damage in lymphocytes.
López E; Guerrero R; Núñez MI; del Moral R; Villalobos M; Martínez-Galán J; Valenzuela MT; Muñoz-Gámez JA; Oliver FJ; Martín-Oliva D; Ruiz de Almodóvar JM
Breast Cancer Res; 2005; 7(5):R690-8. PubMed ID: 16168114
[TBL] [Abstract][Full Text] [Related]
9. Radiation-induced DNA damage as a predictor of long-term toxicity in locally advanced breast cancer patients treated with high-dose hyperfractionated radical radiotherapy.
Pinar B; Lara PC; Lloret M; Bordón E; Núñez MI; Villalobos M; Guerrero R; Luna JD; Ruiz de Almodóvar JM
Radiat Res; 2007 Oct; 168(4):415-22. PubMed ID: 17903032
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast radiosensitivity measured using the comet DNA-damage assay correlates with clonogenic survival parameters.
Eastham AM; Marples B; Kiltie AE; Orton CJ; West CM
Br J Cancer; 1999 Mar; 79(9-10):1366-71. PubMed ID: 10188877
[TBL] [Abstract][Full Text] [Related]
11. Radiosensitivity of peripheral blood lymphocytes from healthy donors and cervical cancer patients; the correspondence of in vitro data with the clinical outcome.
Gabelova A; Farkasova T; Gurska S; Machackova Z; Lukacko P; Witkovsky V
Neoplasma; 2008; 55(3):182-91. PubMed ID: 18348650
[TBL] [Abstract][Full Text] [Related]
12. [Can an extremely elevated radiosensitivity in patients be recognized by the in-vitro testing of lymphocytes?].
Dunst J; Gebhart E; Neubauer S
Strahlenther Onkol; 1995 Oct; 171(10):581-6. PubMed ID: 8571177
[TBL] [Abstract][Full Text] [Related]
13. Relationship between cellular radiosensitivity and DNA damage measured by comet assay in human normal, NBS and AT fibroblasts.
Brammer I; Zoller M; Dikomey E
Int J Radiat Biol; 2001 Sep; 77(9):929-38. PubMed ID: 11576452
[TBL] [Abstract][Full Text] [Related]
14. Relationships between acute reactions to radiotherapy in head and neck cancer patients and parameters of radiation-induced DNA damage and repair in their lymphocytes.
Rzeszowska-Wolny J; Palyvoda O; Polanska J; Wygoda A; Hancock R
Int J Radiat Biol; 2008 Aug; 84(8):635-42. PubMed ID: 18608641
[TBL] [Abstract][Full Text] [Related]
15. Evidence of DNA repair/processing defects in cultured skin fibroblasts from breast cancer patients.
Hannan MA; Siddiqui Y; Rostom A; Al-Ahdal MN; Chaudhary MA; Kunhi M
Cancer Res; 2001 May; 61(9):3627-31. PubMed ID: 11325831
[TBL] [Abstract][Full Text] [Related]
16. Wound healing morbidity in STS patients treated with preoperative radiotherapy in relation to in vitro skin fibroblast radiosensitivity, proliferative capacity and TGF-beta activity.
Akudugu JM; Bell RS; Catton C; Davis AM; Griffin AM; O'Sullivan B; Waldron JN; Ferguson PC; Wunder JS; Hill RP
Radiother Oncol; 2006 Jan; 78(1):17-26. PubMed ID: 16380182
[TBL] [Abstract][Full Text] [Related]
17. DNA double-strand break repair defects in syndromes associated with acute radiation response: at least two different assays to predict intrinsic radiosensitivity?
Joubert A; Zimmerman KM; Bencokova Z; Gastaldo J; Chavaudra N; Favaudon V; Arlett CF; Foray N
Int J Radiat Biol; 2008 Feb; 84(2):107-25. PubMed ID: 18246480
[TBL] [Abstract][Full Text] [Related]
18. Relationship between DNA double-strand breaks, cell killing, and fibrosis studied in confluent skin fibroblasts derived from breast cancer patients.
Dikomey E; Brammer I; Johansen J; Bentzen SM; Overgaard J
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):481-90. PubMed ID: 10661357
[TBL] [Abstract][Full Text] [Related]
19. Normal tissue radiosensitivity in breast cancer patients.
Ramsay J; Birrell G
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):339-44. PubMed ID: 7836087
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of predictive assays for acute and late radiation morbidity.
Budach W; Classen J; Belka C; Bamberg M
Strahlenther Onkol; 1998 Nov; 174 Suppl 3():20-4. PubMed ID: 9830451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
